- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02632383
Young With Diabetes Type 1 - Test of an mHealth App
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Young people with diabetes type 1, their parents and health care providers have participated in developing the mHealth app "Young with Diabetes".
The aim of the app is to support young people to self-manage their diabetes type 1.
A test group of 70 young people with diabetes type 1 test the app for 12 months as a supplement to standard care and the control group receives standard care only.
At baseline and after 2, 7 and 12 months HbA1c, problem areas in diabetes, perceived competences in diabetes and health care climate are measured.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Gentofte, Denmark, 2820
- Steno Diabetes Center
-
Herlev, Denmark, 2730
- Pediatric and Adolescent Department, Herlev Hospital
-
Hillerød, Denmark, 3400
- Department of Cardiology, Nephrology and Endocrinology, Nordsjællands Hospital, Hillerød
-
Hillerød, Denmark, 3400
- Pediatric and Adolescent Department, Nordsjællands Hospital, Hillerød
-
Køge, Denmark, 4600
- Department of Endocrinology, Køge Hospital
-
Roskilde, Denmark, 4000
- Pediatric Department, Roskilde Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Type 1 Diabetes
- 14 to 22 years old
followed at one of the six diabetes departments/centers
- Pediatric and Adolescent Department, Nordsjællands Hospital, Hillerød
- Department of Cardiology, Nephrology and Endocrinology, Nordsjællands Hospital, Hillerød
- Pediatric and Adolescent Department, Herlev Hospital
- Steno Diabetes Center, Gentofte
- Pediatric Department, Roskilde Hospital
- Department of Endocrinology, Køge Hospital
- have an iOS or android smartphone
- last measured HbA1c before sending out recruiting letters: 64 mmol/mol or more (if the last measured HbA1c is older than 6 months at time of baseline visit a new HbA1c is measured and has to be at least 64 mmol/mol before the participant kan be randomized)
- mean of the three last measured HbA1c before sending out recruiting letters: 58 mmol/mol or more (if the third last HbA1c is older than 18 months at time of baseline visit a new HbA1c is measured and has to be at least 64 mmol/mol before the participant kan be randomized)
Exclusion Criteria:
- A psychical or psychiatric disorder that enables them to use the app
- Participates in other diabetes interventions
- Sees a psychologist or psychiatrist
- Have participated in developing the app Young with Diabetes
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Test Group
Intervention: Young with Diabetes - app The test group receives standard care and the mHealth app "Young with Diabetes" - app to support young people to self-manage their diabetes. The young people's parents are also invited to download the app. The diabetes team (doctors, nurses and dieticians) also have the app and uses the app in their consultations with the young people. |
The mHealth app "Young with Diabetes" containes 8 main functions:
|
|
No Intervention: Control Group
The control group receives standard care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Glycemic control measured by HbA1c
Time Frame: Glycemic control is measured by HbA1c at 12 months
|
Glycemic control is measured by HbA1c at 12 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Problem areas in diabetes measured by PAID-20
Time Frame: Problem areas in diabetes are measured by PAID-20 at 12 months
|
Problem areas in diabetes are measured by PAID-20 at 12 months
|
|
Perceived competences in diabetes measured by PCD-questionnaire
Time Frame: Perceived competences in diabetes are measured by PCD-questionnaire at 12 months
|
Perceived competences in diabetes are measured by PCD-questionnaire at 12 months
|
|
Health Care Climate measured by HCCQ-questionnaire
Time Frame: Health Care Climate is measured by HCCQ-questionnaire at 12 months
|
Health Care Climate is measured by HCCQ-questionnaire at 12 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Pernille Castensøe-Seidenfaden, Pediatric and Adolescent Department, Nordsjællands Hospital, Hillerød
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1 (Other Identifier: Mobile Health and Wellness Program)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus, Type 1
-
COUR Pharmaceutical Development Company, Inc.RecruitingType 1 Diabetes | Type 1 Diabetes Mellitus | T1DM | T1D | Type 1 Diabetes in Adolescence | Type 1 Diabetes in Children | Type 1 Diabetes Patients | Type 1 Diabetes Mellitis | T1DM - Type 1 Diabetes Mellitus | Type 1 Diabetes (Juvenile Onset)United States
-
Sultan Qaboos UniversityUniversity of Mosul; University of Child Health Sciences and Children's Hospital...Not yet recruitingType 1 Diabetes Mellitus | T1DM | Type 1 Diabetes Mellitus (T1DM) | T1DM - Type 1 Diabetes Mellitus
-
Lund UniversityEnrolling by invitationType 1 Diabetes Mellitus | Stage 2 Type 1 Diabetes | Stage 1 Type 1 Diabetes | Stage 3 Type 1 DiabetesSweden
-
Superior UniversityActive, not recruitingType 2 Diabetes Mellitus 1Pakistan
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Abdullah KarsNot yet recruitingType 1 Diabetes Mellitus | Autoimmune Diabetes | Type 1 Diabetes Mellitus (T1DM)Turkey (Türkiye)
-
Immunocore LtdNot yet recruitingType 1 Diabetes | Diabetes Type 1 | Type 1 Diabetes (T1D)
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
University of California, San FranciscoJuvenile Diabetes Research FoundationCompletedType 1 Diabetes Mellitus | Diabetes Mellitus, Type I | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | IDDMUnited States, Australia
-
AstraZenecaCompletedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
Clinical Trials on Young with Diabetes - app
-
University of UtahHitachi, Ltd.CompletedDiabetes Mellitus, Type 2 | Diabetes MellitusUnited States
-
Yonsei UniversityNot yet recruitingType 1 Diabetes MellitusKorea, Republic of
-
Massachusetts General HospitalCompletedType 1 Diabetes | Type 2 DiabetesUnited States
-
Northwestern UniversityWashington University School of MedicineActive, not recruiting
-
Leocadio Rodriguez MañasHospital Universitario Getafe; MG Biomed; SocialDiabetesCompletedDiabetes Mellitus | Diabetes | Elderly | ELDERLY PEOPLESpain, Sweden
-
Medical University of SofiaUniversity Hospital for Active Treatment in Endocrinology "Acad Ivan Penchev... and other collaboratorsActive, not recruitingType 1 Diabetes MellitusBulgaria
-
Yunxuan LiRecruitingDiabetes Mellitus, Type 2 | Self-management | Physician-Patient RelationsChina
-
Singapore General HospitalRecruiting
-
Soledad Ruiz de AdanaUnknownDiabetes Mellitus, Type 1Spain
-
New York UniversityNot yet recruitingPre-diabetes | Lifestyle Risk Reduction | Diet Prevention of Metabolic DiseasesUnited Arab Emirates